Germany’s Merck KGaA has presented detailed results from cohort B of the global Phase II WILLOW study of enpatoran, an ...

German science and technology firm Merck KGaA (MRK: DE) has moved a step closer to introducing a new therapy for tenosynovial ...

It remains unclear when production will start. More retail could fill site along K-10 near Panasonic Merck plans $895M ...

Plant Services Smart Minute is a content based enewsletter where readers will find exclusive content, relevant industry news, useful case studies, access to Plant Services on-demand webcasts, and ...

Triple-negative breast cancer (TNBC) - closeup view 3d illustration] Nemes Laszlo/iStock via Gilead Sciences (NASDAQ:GILD [ announced Saturday that its antibody-drug conjugate Trodelvy, in ...

Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's ...

New findings suggest that a PSA level of 0.2 ng/mL or greater can predict a poor prognosis and indicate a possible need for ...

MoonLake Immunotherapeutics' Sonelokimab's Phase 3 trials, PsA market growth, and Merck's $3B bid showcase potential. Read my ...

(MRK) announced that KEYTRUDA (pembrolizumab) plus Trodelvy (sacituzumab govitecan-hziy) reduced the risk of disease progression or death by 35% compared to KEYTRUDA plus chemotherapy for the ...

MRK), and Kansas Governor Laura Kelly jointly announced today the $895 million expansion of Merck Animal Health’s manufacturing facility in De Soto, Kansas.

This week's dividend activity included increased payouts from BMO Financial (BMO) and Royal Bank of Canada (RY) as well as ...